drugset / Trial / NCT01814904
Dose-finding Study of MCI-196
RandomizedParallel-groupOpen-labelTreatment
Summary
The Primary Objective of this study is to determine the initial starting doses of colestilan (MCI-196) in paediatric subjects with Chronic Kidney Disease Stage 5 on Dialysis and with Hyperphosphataemia.
Timeline
- Start
- 2014-04
- Primary completion
- 2015-01
- Completion
- 2015-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | COLESTILAN CHLORIDE | Other / unclassified | 3 g | — |
| Subject | COLESTILAN CHLORIDE | Other / unclassified | 6 g | — |
| Subject | COLESTILAN CHLORIDE | Other / unclassified | 9 g | — |